Catherine Alix-Panabières: Join us at ISMRC 2025 in Nice for AI and Liquid Biopsy breakthroughs
Catherine Alix-Panabières, Professor of Oncology at the Faculty of Medicine of the University of Montpellier, shared a post on LinkedIn by International Symposium on Minimal Residual Cancer, adding:
“Don’t miss ISMRC 2025 in Nice, French Riviera!
If you’re passionate about the future of AI (Artificial Intelligence) in Science and Medicine and the latest breakthroughs in Liquid Biopsy, this is the event to attend.
Join leading experts, researchers, and clinicians for groundbreaking discussions in one of the most beautiful destinations in the world.
See you there!”
Quoting International Symposium on Minimal Residual Cancer’s post:
“How is AI shaping the future of Cancer Research? At ISMRC2025, Miguel Luengo-Oroz, CEO of Spotlab.ai and former UN Chief Data Scientist, will explore ‘AI Horizons: From Societal Transformations to Exploring New Frontiers in AI for Cancer Research.’
Don’t miss this deep dive into the role of AI in diagnostics, biopharma research, and global health.Register now.
The ISMRC2025 is organized by Paul Hofman, Catherine Alix-Panabières and Klaus Pantel.”
More posts featuring Catherine Alix-Panabières.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023